Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

USP25/28 inhibitor AZ1

USP25/28 inhibitor AZ1
USP25/28 inhibitor AZ1 is a selective, orally active and non-competitive dual ubiquitin-specific protease USP25/28 inhibitor with IC50 of 0.7 μM and 0.6 μM, respectively, and exhibits anti-inflammatory and anti-tumor effects.
Catalog No. T7685Cas No. 2165322-94-9
Select Batch
Purity:99.79%
Contact us for more batch information

Resource Download

USP25/28 inhibitor AZ1

Catalog No. T7685Alias AZ1Cas No. 2165322-94-9

USP25/28 inhibitor AZ1 is a selective, orally active and non-competitive dual ubiquitin-specific protease USP25/28 inhibitor with IC50 of 0.7 μM and 0.6 μM, respectively, and exhibits anti-inflammatory and anti-tumor effects.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
500 mg$1,090In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "USP25/28 inhibitor AZ1"

Product Introduction

Bioactivity
Description
USP25/28 inhibitor AZ1 is a selective, orally active and non-competitive dual ubiquitin-specific protease USP25/28 inhibitor with IC50 of 0.7 μM and 0.6 μM, respectively, and exhibits anti-inflammatory and anti-tumor effects.
Targets&IC50
USP28:0.6 nM, USP25:0.7 nM
In vitro
METHODS: HCT116 cells were treated with USP25/28 inhibitor AZ1 (20, 40, 60, 80, 100 μM) and samples were collected 3 hours later for Western blot analysis of USP28, c-Myc and PARP.
RESULTS Western blot analysis showed that the total protein level of c-Myc decreased rapidly and concentration-dependently after treatment with USP25/28 inhibitor AZ1. [1]
In vivo
Method: USP25/28 inhibitor AZ1 (AZ1) (20, 40mg/kg, gavage) was given to WT
Model mice were used to study the effect of USP25/28 inhibitor AZ1 (AZ1) on DSS-induced colitis.
RESULTS USP25/28 inhibitor AZ1 (AZ1) treatment significantly reduced the number of colon tumors; the expression of wnt-related genes and pSTAT3 levels in tumors in the USP25/28 inhibitor AZ1 (AZ1) treatment group were reduced, and the SOCS3 level was increased; USP25/28 inhibitor Inflammation and bacterial replication were impaired in the colon of mice gavaged with AZ1 (AZ1), the expression of pro-inflammatory cytokines and antimicrobial peptides was enhanced, p-p65 and p-p38 levels were increased, and TRAF3 levels were decreased. [2]
AliasAZ1
Chemical Properties
Molecular Weight422.21
FormulaC17H16BrF4NO2
Cas No.2165322-94-9
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 250 mg/mL (592.12 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.3685 mL11.8424 mL23.6849 mL118.4245 mL
5 mM0.4737 mL2.3685 mL4.7370 mL23.6849 mL
10 mM0.2368 mL1.1842 mL2.3685 mL11.8424 mL
20 mM0.1184 mL0.5921 mL1.1842 mL5.9212 mL
50 mM0.0474 mL0.2368 mL0.4737 mL2.3685 mL
100 mM0.0237 mL0.1184 mL0.2368 mL1.1842 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy USP25/28 inhibitor AZ1 | purchase USP25/28 inhibitor AZ1 | USP25/28 inhibitor AZ1 cost | order USP25/28 inhibitor AZ1 | USP25/28 inhibitor AZ1 chemical structure | USP25/28 inhibitor AZ1 in vivo | USP25/28 inhibitor AZ1 in vitro | USP25/28 inhibitor AZ1 formula | USP25/28 inhibitor AZ1 molecular weight